最小化十二指肠镜相关感染风险的策略的成本效用分析
该研究建立蒙特卡洛分析模型,评估单次高水平消毒、双重高水平消毒、环氧乙烷灭菌、培养并滞留、部分一次性十二指肠镜和全一次性十二指肠镜等策略的成本效用,并将十二指肠镜传播感染的成本纳入计算。在感染传播率低于1%时,部分一次性十二指肠镜在成本效用上最有利;全一次性十二指肠镜在感染传播率高于0.32%时优于环氧乙烷灭菌,高于0.56%时优于培养并滞留。
要点
- 在感染传播率低于1%时,部分一次性十二指肠镜在成本效用上最有利。
- 全一次性十二指肠镜在感染传播率高于0.32%时成本效用优于环氧乙烷灭菌。
- 全一次性十二指肠镜在感染传播率高于0.56%时成本效用优于培养并滞留。
核心结论
- 模型提示,对于预期感染传播率极低且一次性部件成本较低的情况,部分一次性十二指肠镜是成本效用上最有利的选择。
- 这些数据强调了成本计算中纳入感染传播风险及患者相关发病率/死亡率的重要性。
研究设计与样本
- 研究在R语言中建立蒙特卡洛分析模型,采用多状态试验框架,评估多种策略的成本效用。
- 评估策略包括单次高水平消毒、双重高水平消毒、环氧乙烷灭菌、培养并滞留、部分一次性十二指肠镜和全一次性十二指肠镜。
- 模型模拟十二指肠镜传播感染导致的质量调整生命年损失,并将其纳入各策略的平均成本。
主要发现
- 在基础模型中,感染传播率低于1%时,部分一次性十二指肠镜在成本效用上最有利。
- 全一次性十二指肠镜在所有感染传播率下成本效用优于单次或双重高水平消毒后的可重复处理十二指肠镜。
- 全一次性十二指肠镜在感染传播率高于0.32%时成本效用优于环氧乙烷灭菌,高于0.56%时优于培养并滞留。
- 医院业务量、质量调整生命年价值、ERCP后寿命和环境成本等替代情景的变化改变了成本效用特征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Transmission of multidrug-resistant organisms by duodenoscopes during ERCP is problematical. The U.S. Food and Drug Administration recently recommended transitioning away from reusable fixed-endcap duodenoscopes to those with innovative device designs that make reprocessing easier, more effective, or unnecessary. Partially disposable (PD) duodenoscopes with disposable endcaps and fully disposable (FD) duodenoscopes are now available. We assessed the relative cost of approaches to minimizing infection transmission, taking into account duodenoscope-transmitted infection cost. METHODS: We developed a Monte Carlo analysis model in R (R Foundation for Statistical Computing, Vienna, Austria) with a multistate trial framework to assess the cost utility of various approaches: single high-level disinfection (HLD), double HLD, ethylene oxide (EtO) sterilization, culture and hold, PD duodenoscopes, and FD duodenoscopes. We simulated quality-adjusted life years (QALYs) lost by duodenoscope-transmitted infection and factored this into the average cost for each approach. RESULTS: At infection transmission rates <1%, PD duodenoscopes were most favorable from a cost utility standpoint in our base model. The FD duodenoscope minimizes the potential for infection transmission and is more favorable from a cost utility standpoint than use of reprocessable duodenoscopes after single or double HLD at all infection rates, EtO sterilization for infection rates >.32%, and culture and hold for infection rates >.56%. Accounting for alternate scenarios of variation in hospital volume, QALY value, post-ERCP lifespan, and environmental cost shifted cost utility profiles. CONCLUSIONS: Our model indicates that PD duodenoscopes represent the most favorable option from a cost utility standpoint for ERCP, with anticipated very low infection transmission rates and a low-cost disposable element. These data underscore the importance of cost calculations that account for the potential for infection transmission and associated patient morbidity/mortality.
引用
- Barakat MT, Ghosh S, Banerjee S, et al. Cost utility analysis of strategies for minimizing risk of duodenoscope-related infections. Gastrointest Endosc. 2022. PMID: 35026281. doi:10.1016/j.gie.2022.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。